Till Acker
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 24
- Developmental Neuroscience top 1%
- Genetics top 1%
- Glioma Diagnosis and Treatment 12
- Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer 13
- ATP Synthase and ATPases Research 6
- Epigenetics and DNA Methylation 5
- Neurology top 2%
- Neuroblastoma Research and Treatments 6
-
- Axon Guidance and Neuronal Signaling 8
-
- Cancer Cells and Metastasis 6
- Co-authors
- Karl H. PlateBoyan K. GarvalovSascha SeidelH. AckerHeike BeckIngo FlammeAmparo Acker‐PalmerAnne Schänzer
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Till Acker
83 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 2.0k
- Developmental Neuroscience 345
- Genetics 668
- Molecular Biology 3.0k
- Neurology 314
Countries citing papers authored by Till Acker
This map shows the geographic impact of Till Acker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Acker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Acker more than expected).
Fields of papers citing papers by Till Acker
This network shows the impact of papers produced by Till Acker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Acker. The network helps show where Till Acker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Till Acker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 8 | |
| 6 | 2020 | 25 | |
| 7 | 2018 | 42 | |
| 8 | 2018 | 112 | |
| 9 | Supporting Molecular Tumor Boards in Molecular-Guided Decision-Making - The Current Status of Five German University Hospitals. | 2017 | 11 |
| 10 | 2016 | 72 | |
| 11 | 2013 | 45 | |
| 12 | 2013 | 24 | |
| 13 | 2011 | 34 | |
| 14 | 2010 | 344 | |
| 15 | 2010 | 432 | |
| 16 | 2008 | 16 | |
| 17 | 2007 | 40 | |
| 18 | 2006 | 67 | |
| 19 | Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature micebreakdown → | 2002 | 590 |
| 20 | 2001 | 68 |
About Till Acker
Till Acker is a scholar working on Cancer Research, Genetics and Developmental Neuroscience, having authored 84 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (24 papers), Angiogenesis and VEGF in Cancer (13 papers), Glioma Diagnosis and Treatment (12 papers), Axon Guidance and Neuronal Signaling (8 papers), ATP Synthase and ATPases Research (6 papers), Neuroblastoma Research and Treatments (6 papers), Cancer Cells and Metastasis (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (2.0k citations), Developmental Neuroscience (345 citations) and Genetics (668 citations). Till Acker has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Karl H. Plate, Boyan K. Garvalov, Sascha Seidel, H. Acker, Heike Beck, Ingo Flamme, Amparo Acker‐Palmer, Anne Schänzer, Anne‐Theres Henze and Clara L. Essmann. Their work appears in journals such as Nature Communications, Brain Pathology, Cancer Research, Journal of Cerebral Blood Flow & Metabolism and Clinical Neuropathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.